ARCHIVES

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

This article is from The Cancer Letter archive.

Vol. 25 No. 30 | July 30, 1999

Download PDF Visit The Full Archive

Related Articles

US Oncology To Participate In Firm’s Ovarian Cancer Trial.

January 26, 2001

In Brief: Mihich, Kennedy, Aust New Presidents; Loeb, Coltman, Cady Presidents Elect; Carbone Honored

May 29, 1987

NCI CTEP Approved Trials For the Month of April

April 25, 2014

Firm Wins Patent For Method, Apparatus For Cryoablation.

December 15, 2000

DeVita Alert Advises That Negative Node Breast Cancer Patients Do Better With Adjuvant Therapy

May 27, 1988

NIH To Replace RAC With New Committee

July 19, 1996